MLSS MILESTONE SCIENTIFIC INC.

BEARISH Impact: 6/10 S-3
Horizon weeks Filed Jun 2, 2026 Processed 10d 11h ago SEC 0001493152-26-026888
Shelf registration — potential dilution
Latest settled — T+1d
MLSS ▲ +11.28% at T+1d
SHORT call ✗ call lost -11.28% · α vs SPY -10.88% · entry $0.3900 → $0.4340
Next anchor: T+5d due 4d ago
Currently $0.3500 · +10.26% from $0.3900 entry (call sign-flipped)
Entry anchored
Jun 2, 03:59 PM ET
via Databento tick
T+1d
+11.28%
call -11.28% · α -10.88%
$0.4340
settled 10d ago
T+5d
call — · α —
due 4d ago
T+20d
call — · α —
in 18d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Milestone Scientific filed a resale S-3 shelf registration covering 15,925,926 shares (7,962,963 Initial Shares + 7,962,963 Warrant Shares) held by selling stockholders from the April 20, 2026 private placement. The company received $2.15M gross from the PIPE ($1.799M cash + $351K note conversion) and will not receive proceeds from resales, though full warrant exercise would yield another $2.6875M. This filing is a contractual obligation, not a new capital raise, but the overhang of shares equal to ~18% of current outstanding creates bearish sentiment given the company's going-concern disclosure, $34M market cap, NYSE American listing deficiency, and operating cash burn of ~$2.9M per year.

Key Financial Metrics

Offering Size
$5.7M

Actionable Insight

The resale S-3 adds an overhang of 18% of shares outstanding, which will pressure MLSS stock as selling stockholders can sell into the market. The company's NYSE American listing remains at risk with equity below $6M despite the PIPE. Monitor for 10-Q filing showing Q1 2026 cash burn and equity position; any delay or auditor change would be highly negative. The upcoming July 27, 2026 annual meeting where stockholder approval for the warrant issuance is sought is also a key catalyst.

Key Facts

  • S-3 registers up to 15,925,926 shares for resale (7,962,963 issued + 7,962,963 warrant shares)
  • Private placement closed April 20, 2026 at $0.27/unit, grossing $2.15M ($1.799M cash + $351K note conversion)
  • Shares outstanding: 88,449,412 as of May 28, 2026; registered shares represent ~18% overhang
  • Warrants exercisable at $0.3375/share for 3 years, could yield $2.6875M if fully exercised
  • Stockholders' equity was $2.8M at Dec 31, 2025; PIPE boosted it to $4.1M (still below the $6M NYSE American threshold for continued listing)
  • Company disclosed going-concern uncertainty, net cash used in operations ~$2.9M in each of 2025 and 2024
  • NYSE American issued non-compliance notice Oct 8, 2025 for equity deficiency; cure deadline April 8, 2027
  • Market cap ~$34M; stock closed at $0.37/share on May 26, 2026
  • Directors/officers participated in PIPE and entered 12-month lock-ups; selling stockholders not locked
  • Company has changed auditors twice in 15 months (Marcum→CBIZ→Grassi)

Financial Impact

Registration covers shares equal to ~18% of outstanding common stock, representing potential dilution overhang of ~$5.7M at $0.36/share filing price. Company has only $4.1M in equity post-PIPE, burns ~$2.9M/year in operations, and has going-concern disclosure.

dilutionmarket capequityliquidity

Risk Factors

  • Resale of 15.9M shares by selling stockholders could depress stock price
  • Going-concern uncertainty may persist; cash burn of ~$2.9M/year exceeds recent PIPE proceeds
  • NYSE American delisting risk if equity remains below $6M by April 2027
  • Auditor changes (Marcum→CBIZ→Grassi within 15 months) raise governance/control concerns
  • Penny stock price ($0.37) and low market cap ($34M) limit institutional interest and access to capital

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
88% bullish (8 analysts)

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
S-3 Filing (Primary)0001493152-26-026888
Exhibit: ex107.htm0001493152-26-026888
Exhibit: ex5-1.htm0001493152-26-026888
Exhibit: ex23-1.htm0001493152-26-026888
Exhibit: ex23-2.htm0001493152-26-026888
Document: 0001493152-26-026888-index-headers.html0001493152-26-026888
Document: 0001493152-26-026888-index.html0001493152-26-026888
Document: 0001493152-26-026888.txt0001493152-26-026888
8 reports for MLSS
Performance horizon
Filters
Rows
Reports for MLSS — sortable, filterable
Type Now
Jun 10, 2026
3d ago
EFFECT
BEARISH ★ 6/10
$0.3869 awaiting T+1awaiting T+1$0.3500 (+9.54%)
Jun 2, 2026
10d ago
S-3
BEARISH ★ 6/10
$0.3900 $0.4340▼ −11.28%▼ −10.88%$0.3500 (+10.26%)
May 27, 2026
16d ago
Press Release
NEUTRAL ★ 4/10
$0.3900 $0.4000▲ +2.56%▲ +2.01%$0.3500 (−10.26%)
May 14, 2026
29d ago
Press Release
NEUTRAL ★ 4/10
$0.3400 $0.3300▼ −2.94%▼ −1.71%$0.3500 (+2.94%)
May 6, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$0.4700 $0.4600▼ −2.13%▼ −2.96%$0.3500 (−25.53%)
May 6, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$0.4700 $0.4600▼ −2.13%▼ −2.96%$0.3500 (−25.53%)
Apr 21, 2026
7w ago
8-K
NEUTRAL ★ 4/10
$0.3200 $0.3400▲ +6.25%▲ +5.23%$0.3500 (+9.37%)
Apr 21, 2026
7w ago
Press Release
NEUTRAL ★ 5/10
$0.3200 $0.3400▲ +6.25%▲ +5.23%$0.3500 (+9.37%)
Showing 8 of 8

US Market Status

Market Closed — Opens Mon (53h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access